| Literature DB >> 26520433 |
Howard E Gendelman1, R Lee Mosley2.
Abstract
Aberrant innate and adaptive immune responses are neurodegenerative disease effectors. Disease is heralded by a generalized, but subtle immune activation orchestrated by the release of extracellular prion-like aggregated and oxidized or otherwise modified proteins. These are responsible for an inflammatory neurotoxic cascade. The perpetrators of such events include effector T cells and activated microglia. What ensues are Alzheimer's and Parkinson's disease, amyotrophic lateral sclerosis and stroke with changed frequencies of effector T cell and reduced numbers or function of regulatory lymphocytes. The control of such immune responses could lead to new therapeutic strategies and the means to effectively combat a composite of diseases that have quite limited therapeutic options.Entities:
Keywords: Adaptive immunity; Alzheimer’s disease; Amyotrophic lateral sclerosis; Effector T cells; Innate immunity; Neurodegenerative diseases; Neurodestruction; Neuroprotection; Parkinson’s disease; Regulatory T cells; Stroke
Mesh:
Year: 2015 PMID: 26520433 PMCID: PMC4662620 DOI: 10.1007/s11481-015-9639-4
Source DB: PubMed Journal: J Neuroimmune Pharmacol ISSN: 1557-1890 Impact factor: 4.147